Avidity Partners Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
PA
CS
CAM
BBA
AC
EAM
Avidity Partners Management's ZYME Position: Q1 2021 in Review
Avidity Partners Management sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 578,100 shares — an estimated $27.3M sold.
Avidity Partners Management first reported a position in ZYME in Q3 2020 and held it in 2 quarters. The position peaked at $27.3M in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.
- Avidity Partners Management reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
- Avidity Partners Management sold 578,100 Zymeworks shares in Q1 2021, an estimated $27.3M.
- Avidity Partners Management first reported a position in Zymeworks in Q3 2020 and held it in 2 quarters.
- Avidity Partners Management's Zymeworks position peaked at $27.3M in Q4 2020.
- 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.
Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.